Morning SPAC News Roundup: September 24, 2024

At the SPAC of Dawn Congress hasn’t done much for SPACs in some time, but it appears poised to boost at least one category of transactions in the coming weeks. The House yesterday passed a wide-ranging bill yesterday that extends and clarifies some of the exclusivity protections and preferential review processes for certain drug candidates
Read More